Standex International Corp/de/ Form 4 insider transactions

Standex International reports that Vice President, CFO, and Treasurer Ademir Sarcevic forfeited 1,713 shares of common stock to cover tax liabilities related to restricted stock vesting.

Standex International Director Thomas E. Chorman reported a sale of 50 shares of common stock on April 1, 2026, executed under a pre-existing 10b5-1 trading plan.

Standex International Director Thomas E. Chorman reported the sale of 50 common shares at $259 each, executed under a pre-arranged 10b5-1 trading plan.

Standex International Director Thomas E. Chorman filed a Form 4 disclosing a planned sale of 513 common shares on February 27, 2026, under a Rule 10b5-1 trading plan.

Standex International Corp. Director Barbara Joanne Edwards reported gifting 58 shares of common stock, reducing her direct beneficial ownership to 6,227 shares.

Standex International's Chief Strategy Officer, Vineet Kshirsagar, sold 400 shares of common stock for $260.10 per share under a pre-arranged trading plan.

Standex International Director Thomas E. Chorman sold 50 shares of common stock for $249.86 per share under a pre-arranged 10b5-1 plan.

A Standex International director plans to acquire 2,000 shares of common stock at $245 per share in a pre-arranged transaction set for February 4, 2026.

Standex International Director Charles H. Cannon Jr. transferred 1,295 shares of common stock to a family trust, as reported in a Form 4 filing.

Standex International Director Thomas E. Chorman reported selling 1,000 shares of common stock for $223.31 per share on November 20, 2025, under a Rule 10b5-1 plan.

Standex International Director Andy L. Nemeth amended a Form 4 to correct a reported stock acquisition to an open market purchase of 1,500 shares at $205.

Standex International Director Andy Nemeth amended a Form 4 filing to correct the transaction code for a purchase of 2,000 shares of common stock.

Standex International's Chief HR Officer, Michelle Newbury, was granted restricted stock, phantom stock units, and restricted stock units as part of the company's incentive plan.

Standex International's Chief Strategy Officer, Vineet Kshirsagar, reported the sale of 650 shares of common stock for approximately $233.37 per share.

Standex International's VP/CFO/Treasurer, Ademir Sarcevic, sold 1,823 shares of common stock for approximately $230.12 per share under a pre-arranged Rule 10b5-1 plan.

Standex International's VP, Chief HR Officer, Annemarie Bell, forfeited 111 shares of common stock to cover tax liabilities related to restricted stock vesting.

Standex International Director Thomas E. Chorman was granted 639 shares of common stock as restricted stock, vesting in three years.

Standex International Director Michael A. Hickey was granted 639 shares of restricted common stock, vesting in three years.

Standex International Director Jeffrey S. Edwards was granted 639 shares of restricted common stock, vesting in three years, under the company's 2018 Omnibus Incentive Plan.

Standex International Director Robin J Davenport received a grant of 639 shares of common stock as restricted stock, vesting in three years.

Barbara Joanne Edwards, a Director at Standex International Corp, received a grant of 639 shares of common stock under the company's incentive plan.

Standex International Director Andy L. Nemeth was granted 639 shares of restricted common stock, increasing his beneficial ownership to 6,639 shares.

Standex International Director Charles H. Cannon Jr. was granted 639 shares of common stock as restricted stock, vesting in three years.

Standex International Director Thomas J. Hansen retired, leading to the vesting of his phantom stock units into common shares.

Standex International Corp. President, CEO, and Chairman David A. Dunbar sold 18,000 shares of common stock for $235 per share under a pre-arranged 10b5-1 trading plan.

Standex International's VP & Chief Accounting Officer, Danielle Rangel, acquired 7 shares of common stock through an employee stock purchase plan.

Standex International Corp's President, CEO, and Chairman, David A. Dunbar, sold 11,000 shares of common stock for $215 per share under a pre-arranged 10b5-1 trading plan.

Standex International Corp's President, CEO, and Chairman, David A. Dunbar, transferred 17,397 shares of common stock to a revocable trust.

Standex International's VP, Chief HR Officer, Annemarie Bell, sold 1,184 shares of common stock for $202.12 per share under a Rule 10b5-1 plan.

Standex International Director Andy Nemeth filed a Form 4 indicating a planned acquisition of 1,500 shares of common stock at $205 per share on August 29, 2025, under a Rule 10b5-1 plan.